Get the Stockscreener App
72.92
1.38%
-1.02
Edwards Lifesciences Corp stock is traded at $72.92, with a volume of 1.56M.
It is down -1.38% in the last 24 hours and down -5.99% over the past month.
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
See More
Previous Close:
$73.94
Open:
$73.17
24h Volume:
1.56M
Relative Volume:
0.36
Market Cap:
$42.81B
Revenue:
$5.69B
Net Income/Loss:
$1.41B
P/E Ratio:
10.44
EPS:
6.9828
Net Cash Flow:
$577.90M
1W Performance:
-4.75%
1M Performance:
-5.99%
6M Performance:
+5.07%
1Y Performance:
+7.03%
1-Day Range:
$72.70
$73.69
1-Week Range:
$72.70
$78.04
52-Week Range:
$64.89
$83.00
Edwards Lifesciences Corp Stock (EW) Company Profile
Name
Edwards Lifesciences Corp
Sector
Industry
Phone
(949) 250-2500
Address
ONE EDWARDS WAY, IRVINE, CA
Compare EW with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EW
Edwards Lifesciences Corp
|
72.91 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
|
ABT
Abbott Laboratories
|
131.62 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.42 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
366.12 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.75 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-08-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-29-25 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-24-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-30-25 | Upgrade | Stifel | Hold → Buy |
| Jan-16-25 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Dec-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-11-24 | Resumed | Morgan Stanley | Equal-Weight |
| Sep-18-24 | Downgrade | Jefferies | Buy → Hold |
| Jul-31-24 | Upgrade | Daiwa Securities | Neutral → Outperform |
| Jul-29-24 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jul-25-24 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-25-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-25-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jul-25-24 | Downgrade | TD Cowen | Buy → Hold |
| Jul-25-24 | Downgrade | Truist | Buy → Hold |
| May-30-24 | Initiated | Goldman | Buy |
| May-22-24 | Upgrade | Citigroup | Neutral → Buy |
| May-14-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Mar-07-24 | Upgrade | BofA Securities | Neutral → Buy |
| Feb-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Nov-28-23 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Sep-26-23 | Upgrade | Oppenheimer | Perform → Outperform |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| Mar-29-23 | Initiated | UBS | Neutral |
| Mar-08-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Feb-06-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-31-23 | Downgrade | Bernstein | Outperform → Underperform |
| Jan-30-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-06-22 | Downgrade | Stifel | Buy → Hold |
| Oct-28-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-26-22 | Initiated | Mizuho | Buy |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-29-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Apr-13-22 | Initiated | Truist | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Feb-02-22 | Upgrade | UBS | Neutral → Buy |
| Jan-27-22 | Reiterated | Citigroup | Buy |
| Jan-27-22 | Reiterated | Evercore ISI | Outperform |
| Jan-27-22 | Reiterated | Raymond James | Outperform |
| Jan-27-22 | Reiterated | Stifel | Buy |
| Jan-27-22 | Reiterated | UBS | Neutral |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Dec-06-21 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jul-30-21 | Reiterated | Canaccord Genuity | Buy |
| Jul-30-21 | Reiterated | Deutsche Bank | Hold |
| Jul-30-21 | Reiterated | Jefferies | Buy |
| Jul-30-21 | Reiterated | Morgan Stanley | Overweight |
| Jul-30-21 | Reiterated | Oppenheimer | Outperform |
| Jul-30-21 | Reiterated | Stifel | Buy |
| Jul-30-21 | Reiterated | UBS | Neutral |
| Jul-30-21 | Reiterated | Wells Fargo | Equal Weight |
| May-25-21 | Initiated | Barclays | Overweight |
| Apr-15-21 | Initiated | Atlantic Equities | Neutral |
| Apr-05-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-11-20 | Reiterated | Canaccord Genuity | Buy |
| Sep-11-20 | Initiated | Wolfe Research | Underperform |
| Apr-28-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-17-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Neutral |
| Feb-06-20 | Resumed | BTIG Research | Neutral |
| Jan-10-20 | Initiated | Oppenheimer | Outperform |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-24-19 | Reiterated | Canaccord Genuity | Buy |
| Sep-23-19 | Initiated | Piper Jaffray | Overweight |
| Jul-24-19 | Reiterated | BofA/Merrill | Buy |
| Mar-18-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-18-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Hold |
| Nov-28-18 | Initiated | UBS | Neutral |
| Oct-16-18 | Initiated | Barclays | Underweight |
| Oct-02-18 | Downgrade | BofA/Merrill | Buy → Neutral |
| Oct-02-18 | Downgrade | Guggenheim | Buy → Neutral |
View All
Edwards Lifesciences Corp Stock (EW) Latest News
What is the fair value of Edwards Lifesciences Corporation stock nowWeekly Market Outlook & Target Return Focused Stock Picks - newser.com
Aberdeen Group plc Increases Position in Edwards Lifesciences Corporation $EW - MarketBeat
OFI Invest Asset Management Has $26.57 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Stonehage Fleming Financial Services Holdings Ltd Makes New Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Callan Family Office LLC Boosts Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
EW Investor News: Rosen Law Firm Investigates Breaches of - GlobeNewswire
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW - GlobeNewswire Inc.
Real time breakdown of Edwards Lifesciences Corporation stock performanceGDP Growth & Weekly Market Pulse Updates - newser.com
Ranking Edwards Lifesciences Corporation among high performing stocks via toolsPortfolio Risk Summary & Low Drawdown Momentum Trade Ideas - newser.com
Blair William & Co. IL Has $30.51 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
What machine learning models say about Edwards Lifesciences CorporationWeekly Trade Report & Weekly Breakout Watchlists - newser.com
Visual trend scoring systems applied to Edwards Lifesciences Corporation2025 Analyst Calls & Reliable Volume Spike Alerts - newser.com
Vontobel Holding Ltd. Reduces Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (EW): Assessing Valuation Following Recent Share Price Decline - Yahoo Finance
Edwards Lifesciences (NYSE:EW) Given "Hold (C)" Rating at Weiss Ratings - MarketBeat
Here's What to Expect From Edwards Lifesciences’ Next Earnings Report - MSN
Edwards Lifesciences Leads Healthcare Stocks in S&P 500 - Kalkine Media
Edwards Lifesciences' Long-Term Plan Raises Concerns Amid 'Structural' Risks, Oppenheimer Says - MarketScreener
Edwards Lifesciences (NYSE:EW) Upgraded at Evercore ISI - MarketBeat
Edwards Lifesciences stock downgraded by Oppenheimer on structural concerns - Investing.com
Oppenheimer Downgrades Edwards Lifesciences to Market Perform From Outperform - MarketScreener
Edwards Lifesciences Corporation $EW Shares Bought by Mirova US LLC - MarketBeat
Shell Asset Management Co. Acquires 19,014 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (EW) Upgraded by Evercore ISI - GuruFocus
Edwards Lifesciences (EW) Receives Analyst Upgrade and Price Tar - GuruFocus
Edwards Lifesciences stock maintains Overweight rating ahead of PARTNER 3 data - Investing.com
Edwards Lifesciences stock upgraded by Evercore ISI on reduced competition - Investing.com
Evercore ISI Upgrades Edwards Lifesciences to Outperform From In Line, Adjusts PT to $88 From $80 - MarketScreener
Seamount Financial Group Inc. Invests $259,000 in Edwards Lifesciences Corporation $EW - MarketBeat
QRG Capital Management Inc. Trims Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Here's What To Expect From Edwards Lifesciences’ Next Earnings Report - Barchart.com
Edwards Lifesciences Corporation $EW Shares Bought by Comprehensive Financial Consultants Institutional Inc. - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Short Interest Update - MarketBeat
Edwards Lifesciences Corporation $EW Shares Bought by Mirae Asset Global Investments Co. Ltd. - MarketBeat
EW Investor News: If You Have Suffered Losses in Edwards - GlobeNewswire
Edwards Lifesciences Corporation $EW Shares Sold by OLD National Bancorp IN - MarketBeat
Hilltop National Bank Purchases Shares of 8,856 Edwards Lifesciences Corporation $EW - MarketBeat
Lbp Am Sa Takes Position in Edwards Lifesciences Corporation $EW - MarketBeat
River Street Advisors LLC Buys Shares of 5,240 Edwards Lifesciences Corporation $EW - MarketBeat
Cooper Financial Group Makes New $373,000 Investment in Edwards Lifesciences Corporation $EW - MarketBeat
17,034 Shares in Edwards Lifesciences Corporation $EW Bought by USA Financial Formulas - MarketBeat
What high frequency data says about Edwards Lifesciences CorporationJuly 2025 WrapUp & Entry Point Strategy Guides - newser.com
Ninety One SA PTY Ltd Sells 5,206 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Ninety One UK Ltd Sells 64,875 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Park Avenue Securities LLC Makes New Investment in Edwards Lifesciences Corporation $EW - Defense World
Real time alert setup for Edwards Lifesciences Corporation performance2025 Valuation Update & Reliable Momentum Entry Alerts - newser.com
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences CorporationEW - MarketScreener
One Wealth Advisors LLC Sells 9,296 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Will Edwards Lifesciences Corporation stock return to pre crisis levelsRate Hike & Risk Managed Investment Entry Signals - newser.com
Is It Time To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)? - Yahoo Finance
Edwards Lifesciences Corporation $EW Shares Sold by Capital Insight Partners LLC - MarketBeat
Edwards Lifesciences Corp Stock (EW) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.68%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):